[Therapeutic efficacy of chloroquine in the uncomplicated malaria due to Plasmodium falciparum in hospital patients in central Ivory Coast (1997-2000)].
A study in vivo of Plasmodium falciparum sensitivity to chloroquine was carried out from April 1997 to February 2000 at Yamoussoukro, Kossou and Bouaké in the central region of Côte d'Ivoire. This study was included in the national Plasmodium falciparum-sensitivity program. One hundred and sixteen subjects consulting for suspected malaria were included according to the WHO's standard of 14 days. Chloroquine was administered on a dosage of 25 mg/kg, spread over three days. Among 108 subjects who finished the treatment, 26.9% (29/108) had therapeutic failure to chloroquine (23 precocious therapeutic failure and 6 late therapeutic failure). Chloroquine was more efficacious in Yamoussoukro (87.5% of clinical appropriate response) and Bouaké (82.5%) than in Kossou (61.7%). Parasitic reduction on subjects with therapeutic failure was higher than 85%. The risk of therapeutic failure is not linked to age of patient. Before a revaluation of this situation, chloroquine should always be recommended as a first-line treatment for uncomplicated malaria for the local populations.
Adou-Bryn
K D
KD
Laboratoire de parasitologie-mycologie, UFR des sciences médicales, B.P.V 166 Abidjan, Côte d'Ivoire.
Krelo
K
K
Akoussi
C F G
CF
Boni
N M C
NM
Yapo
G C
GC
Penali
L K
LK
Ouhon
J
J
Assoumou
A
A
Ehouman
A
A
D000367:Age Factors; D000962:Antimalarials / Q000627:therapeutic use*; D002675:Child, Preschool; D002738:Chloroquine / Q000627:therapeutic use*; D007560:Cote d'Ivoire / Q000453:epidemiology; D004334:Drug Administration Schedule; D006760:Hospitalization; D006801:Humans; D007223:Infant; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000453:epidemiology / Q000469:parasitology*; D021261:Parasitic Sensitivity Tests; D018579:Patient Selection; D011159:Population Surveillance; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000962:Antimalarials; D002738:Chloroquine